Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 26, 2020; 8(16): 3458-3464
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3458
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3458
Significance of serum fibroblast growth factor-23 and miR-208b in pathogenesis of atrial fibrillation and their relationship with prognosis
Jie-Min Chen, Yao-Tang Zhong, Chang Tu, Jun Lan, Department of Cardiovascular Medicine, Dongguan Songshan Lake Central Hospital, Dongguan Institute of Cardiovascular Disease, Dongguan 523326, Guangdong Province, China
Author contributions: Chen JM and Zhong YT designed this retrospective study; Chen JM wrote this paper; Tu C was responsible for sorting the data.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Dongguan Songshan Lake Central Hospital.
Informed consent statement: Informed consent was obtained from the patients.
Conflict-of-interest statement: Dr. Lan J reports a grant from Dongguan Social Science and Technology Development Project (No. 2015108101025) during the conduct of the study. Other authors have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Jun Lan, MD, Chief Physician, Department of Cardiovascular Medicine, Dongguan Songshan Lake Central Hospital, Dongguan Institute of Cardiovascular Disease, No. 1 Xianglong Road, Dongguan 523326, Guangdong Province, China. dglanjun@163.com
Received: April 9, 2020
Peer-review started: April 9, 2020
First decision: April 29, 2020
Revised: May 12, 2020
Accepted: July 14, 2020
Article in press: July 14, 2020
Published online: August 26, 2020
Processing time: 137 Days and 23.8 Hours
Peer-review started: April 9, 2020
First decision: April 29, 2020
Revised: May 12, 2020
Accepted: July 14, 2020
Article in press: July 14, 2020
Published online: August 26, 2020
Processing time: 137 Days and 23.8 Hours
Core Tip
Core tip: In this study, the authors investigated the levels and significance of serum fibroblast growth factor 23 and miR-208b in patients with atrial fibrillation and their relationship with prognosis.